The Evolution of Antibiotic resistance

Genetics and Evolution of Infectious Diseases

Volumn , Issue , 2011, Pages 305-337

  González Candelas, Fernando ^a,b   Comas, Iñaki ^c   Luis Martínez, José ^b,d   Carlos Galán, Juan ^b,e   Baquero, Fernando ^b,e  

^a UNIVERSITY OF VALENCIA   (Spain)

^b CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^c NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

^d CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

^e HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882535796     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-384890-1.00012-1     Document Type: Chapter

References (151)

1. Adam M., Murali B., Glenn N.O. Epigenetic inheritance based evolution of antibiotic resistance in bacteria. BMC Evol. Biol. 2008, 8:52.
2. Aendekerk S., Ghysels B., Cornelis P., Baysse C. Characterization of a new efflux pump, MexGHI-OpmD, from Pseudomonas aeruginosa that confers resistance to vanadium. Microbiology 2002, 148:2371-2381.
3. Aendekerk S., Diggle S.P., Song Z., Hoiby N., Cornelis P., Williams P., et al. The MexGHI-OpmD multidrug efflux pump controls growth, antibiotic susceptibility and virulence in Pseudomonas aeruginosa via 4-quinolone-dependent cell-to-cell communication. Microbiology 2005, 151:1113-1125.
4. Allen H.K., Moe L.A., Rodbumner J., Gaarder A., Handelsman J. Functional metagenomics reveals diverse β-lactamases in a remote Alaskan soil. ISME J. 2009, 3:243-251.
5. Alonso A., Rojo F., Martinez J.L. Environmental and clinical isolates of Pseudomonas aeruginosa show pathogenic and biodegradative properties irrespective of their origin. Environ. Microbiol. 1999, 1:421-430.
6. Andersson D.I. The biological cost of mutational antibiotic resistance: any practical conclusions?. Curr. Opin. Microbiol. 2006, 9:461-465.
7. Andersson D.I., Hughes D. Antibiotic resistance and its cost: is it possible to reverse resistance?. Nat. Rev. Microbiol. 2010, 8:260-271.
8. Ando H., Kondo Y., Suetake T., Toyota E., Kato S., Mori T., et al. Identification of katG mutations associated with high-level isoniazid resistance in Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 2010, 54:1793-1799.
9. Arias C.A., Murray B.E. Emergence and management of drug-resistant enterococcal infections. Expert. Rev. Anti. Infect. Ther. 2008, 6:637-655.
10. Austin D.J., Kristinsson K.G., Anderson R.M. The relationship between the volume of antimicrobial consumption in human communities and the frequency of resistance. Proc. Natl. Acad. Sci. U.S.A. 1999, 96:1152-1156.
11. Balsalobre L., de la Campa A.G. Fitness of Streptococcus pneumoniae fluoroquinolone-resistant strains with topoisomerase IV recombinant genes. Antimicrob. Agents Chemother. 2008, 52:822-830.
12. Baquero F. From pieces to patterns: evolutionary engineering in bacterial pathogens. Nat. Rev. Microbiol. 2004, 2:510-518.
13. Baquero F. Evaluation of risks and benefits of consumption of antibiotics: from individual to public health. Encyclopedia of Infectious Diseases 2007, 509-520. Wiley and Sons, Inc., Hoboken, NJ. M. Tibayrenc (Ed.).
14. Baquero F. Prediction: evolutionary trajectories and planet medicine. Microb. Biotech. 2009, 2:130-132.
15. Baquero F. Environmental stress and evolvability in microbial systems. Clin. Microbiol. Infect. 2009, 15(Suppl. 1):5-10.
16. Baquero M.R., Nilsson A.I., Turrientes M.C., Sandvang D., Galán J.C., Martínez J.L., et al. Polymorphic mutation frequencies in Escherichia coli: emergence of weak mutator in clinical isolates. J. Bacteriol. 2004, 186:5538-5542.
17. Baquero F., Martínez J.L., Cantón R. Antibiotics and antibiotic resistance in water environments. Curr. Opin. Biotechnol. 2008, 19:260-265.
18. Barlow M., Fatollahi J., Salverda M. Evidence for recombination among the alleles encoding TEM and SHV β-lactamases. J. Antimicrob. Chemother. 2009, 63:256-259.
19. Barry C.E. Mycobacterium smegmatis: an absurd model for tuberculosis?. Trends Microbiol. 2001, 9:473-474.
20. Benveniste R., Davies J. Aminoglycoside antibiotic-inactivating enzymes in actinomycetes similar to those present in clinical isolates of antibiotic-resistant bacteria. Proc. Natl. Acad. Sci. U.S.A. 1973, 70:2276-2280.
21. Bergstrom C.T., Lo M., Lipsitch M. Ecological theory suggests that antimicrobial cycling will not reduce antimicrobial resistance in hospitals. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:13285-13290.
22. Bjorkman J., Nagaev I., Berg O.G., Hughes D., Andersson D.I. Effects of environment on compensatory mutations to ameliorate costs of antibiotic resistance. Science 2000, 287:1479-1482.
23. Blázquez J. Hypermutation as a factor contributing to the acquisition of antimicrobial resistance. Clin. Infect. Dis. 2003, 37:1201-1209.
24. Blázquez J., Baquero M.R., Canton R., Alos I., Baquero F. Characterization of a new TEM-type β-lactamase resistant to clavulanate, sulbactam, and tazobactam in a clinical isolate of Escherichia coli. Antimicrob. Agents Chemother. 1993, 37:2059-2063.
25. Borrell S., Gagneux S. Infectiousness, reproductive fitness and evolution of drug-resistant Mycobacterium tuberculosis. Int. J. Tuberc. Lung Dis. 2009, 13:1456-1466.
26. Breidenstein E.B., Khaira B.K., Wiegand I., Overhage J., Hancock R.E. Complex ciprofloxacin resistome revealed by screening a Pseudomonas aeruginosa mutant library for altered susceptibility. Antimicrob. Agents Chemother. 2008, 52:4486-4491.
27. Brown M.G., Balkwill D.L. Antibiotic resistance in bacteria isolated from the deep terrestrial subsurface. Microb. Ecol. 2009, 57:484-493.
28. Brückner R., Nuhn M., Reichmann P., Weber B., Hakenbeck R. Mosaic genes and mosaic chromosomes-genomic variation in Streptococcus pneumoniae. Int. J. Med. Microbiol. 2004, 294:157-168.
29. Burse A., Weingart H., Ullrich M.S. The phytoalexin-inducible multidrug efflux pump AcrAB contributes to virulence in the fire blight pathogen, Erwinia amylovora. Mol. Plant Microbe Interact. 2004, 17:43-54.
30. Bush K., Jacoby G.A. Update functional classification of β-lactamase. Antimicrob. Agents Chemother. 2010, 54:969-976.
31. Campbell E.A., Korzheva N., Mustaev A., Murakami K., Nair S., Goldfarb A., Darst S.A. Structural mechanism for rifampicin inhibition of bacterial RNA polymerase. Cell 2001, 104:901-912.
32. Comas I., Chakravarti J., Small P.M., Galagan J., Niemann S., Kremer K., et al. Human T cell epitopes of Mycobacterium tuberculosis are evolutionarily hyperconserved. Nat. Genet. 2010, 42:498-503.
33. Coque T.M., Novais A., Carattoli A., Poirel L., Pitout J., Peixe L., et al. Dissemination of clonally related Escherichia coli strains expressing extended-spectrum β-lactamase CTX-M-15. Emerg. Infect. Dis. 2008, 14:195-200.
34. Couce A., Blázquez J. Side effects of antibiotics on genetic variability. FEMS Microbiol. Rev. 2009, 33:531-538.
35. Da Re S., Garnier F., Guérin E., Campoy S., Denis F., Ploy M.C. The SOS response promotes qnrB quinolone-resistance determinant expression. EMBO Rep. 2009, 10:929-933.
36. D'Acosta V.M., McGrann K.M., Hughes D.W., Wright G.D. Sampling the antibiotic resistome. Science 2006, 311:374-377.
37. Datta N., Hughes V.M. Plasmids of the same Inc groups in Enterobacteria before and after the medical use of antibiotics. Nature 1983, 306:616-617.
38. Davies J. Inactivation of antibiotics and the dissemination of resistance genes. Science 1994, 264:375-382.
39. Davies J.E. Origins, acquisition and dissemination of antibiotic resistance determinants. Ciba Found. Symp. 1997, 207:15-27.
40. Dawkins R. The Selfish Gene 1976, Oxford University Press, New York.
41. De Lencastre H., Tomasz A. Multiple stages in the evolution of the methicillin resistant Staphylococcus aureus. Evolutionary Biology of Bacterial and Fungal Pathogens 2008, ASM Press, Washington, DC. F. Baquero, C. Nombela, G.H. Cassell, J.A. Gutierrez-Fuentes. (Eds.).
42. Dotsch A., Becker T., Pommerenke C., Magnowska Z., Jansch L., Haussler S. Genome-wide identification of genetic determinants of antimicrobial drug resistance in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 2009, 53:2522-2531.
43. Elena S.F., Lenski R.E. Evolution experiments with microorganisms: the dynamics and genetic bases of adaptation. Nat. Rev. Genet. 2003, 4:457-469.
44. Ezekiel D.H., Hutchins J.E. Mutations affecting RNA polymerase associated with rifampicin resistance in Escherichia coli. Nature 1968, 220:276-277.
45. Fajardo A., Martinez-Martin N., Mercadillo M., Galan J.C., Ghysels B., Matthijs S., et al. The neglected intrinsic resistome of bacterial pathogens. PLoS ONE 2008, 3:e1619.
46. Gagneux S., Burgos M.V., DeRiemer K., Encisco A., Munoz S., Hopewell P.C., et al. Impact of bacterial genetics on the transmission of isoniazid-resistant Mycobacterium tuberculosis. PLoS Pathog. 2006, 2:e61.
47. Gagneux S., Long C.D., Small P.M., Van T., Schoolnik G.K., Bohannan B.J.M. The competitive cost of antibiotic resistance in Mycobacterium tuberculosis. Science 2006, 312:1944-1946.
48. Galán J.C., Morosini M.I., Baquero M.R., Reig M., Baquero F. Haemophilus influenzae bla(ROB-1) mutations in hypermutagenic ΔampC Escherichia coli conferring resistance to cefotaxime and β-lactamase inhibitors and increased susceptibility to cefaclor. Antimicrob. Agents Chemother. 2003, 47:2551-2557.
49. Goossens H. Antibiotic consumption and link to resistance. Clin. Microbiol. Infect. 2009, (Suppl. 3):12-15.
50. Gootz T.D. The global problem of antibiotic resistance. Crit. Rev. Immunol. 2010, 30:79-103.
51. Guillemot D., Varon E., Bernède C., Weber P., Henriet L., Simon S., et al. Reduction of antibiotic use in the community reduces the rate of colonization with penicillin G-nonsusceptible Streptococcus pneumoniae. Clin. Infect. Dis. 2005, 41:930-938.
52. Hanage W.P., Fraser C., Tang J., Connor T.R., Corander J. Hyper-recombination, diversity, and antibiotic resistance in Pneumococcus. Science 2009, 324:1454-1457.
53. Huang W., Petrosino J., Hirsch M., Shenkin P.S., Palzkill T. Amino acid sequence determinants of β-lactamase structure and activity. J. Mol. Biol. 1996, 258:688-703.
54. Hughes A.L. Evidence for abundant slightly deleterious polymorphisms in bacterial populations. Genetics 2005, 169:533-538.
55. Humeniuk C., Arlet G., Gautier V., Grimont P., Labia R., Philippon A. β-lactamases of Kluyvera ascorbata, probable progenitors of some plasmid-encoded CTX-M types. Antimicrob. Agents Chemother. 2002, 46:3045-3049.
56. Karageorgopoulos D.E., Falagas M.E. Current control and treatment of multidrug-resistant Acinetobacter baumanii infections. Lancet Infect. Dis. 2008, 8:751-762.
57. Kimura M. Evolutionary rate at the molecular level. Nature 1968, 217:624-626.
58. Kimura M. The Neutral Theory of Molecular Evolution 1983, Cambridge University Press, Cambridge.
59. Knapp C.W., Dolfing J., Ehlert P.A., Graham D.W. Evidence of increasing antibiotic resistance gene abundances in archived soils since 1940. Environ. Sci. Technol. 2010, 44:580-587.
60. Kohler T., van Delden C., Curty L.K., Hamzehpour M.M., Pechere J.C. Overexpression of the MexEF-OprN multidrug efflux system affects cell-to-cell signalling in Pseudomonas aeruginosa. J. Bacteriol. 2001, 183:5213-5222.
61. Kugelberg E., Kofoid E., Andersson D.I., Lu Y., Mellor J., Roth F.P., et al. The tandem inversion duplication in Salmonella enterica: selection drives unstable precursors to final mutation types. Genetics 2010, 185:65-80.
62. Lauretti L., Riccio M.L., Mazzariol A., Cornaglia G., Amicosante G., Fontana R., et al. Cloning and characterization of blaVIM, a new integron-borne metalloβ-lactamase gene from a Pseudomonas aeruginosa clinical isolate. Antimicrob. Agents Chemother. 1999, 43:1584-1590.
63. Levin B.R. Minimizing potential resistance: a population dynamics view. Clin. Infect. Dis. 2001, 33(Suppl. 3):S161-S169.
64. Levin B.R., Perrot V., Walker N. Compensatory mutations, antibiotic resistance and the population genetics of adaptive evolution in bacteria. Genetics 2000, 154:985-997.
65. Levy S.B., Marshall B. Antibacterial resistance worldwide: cause, challenges and responses. Nat. Med. 2004, 10(Suppl. 12):S122-S129.
66. Lindberg F., Normark S. Contribution of chromosomal beta-lactamases to β-lactam resistance in enterobacteria. Rev. Infect. Dis. 1986, 8(Suppl. 3):S292-S304.
67. Livermore D.M. Has the era of untreatable infections arrived?. J. Antimicrob. Chemother. 2009, (Suppl. 1):i29-i36.
68. Livermore D.M., Warner M., Hall L.M., Enne V.I., Projan S.J., Dunman P.M., et al. Antibiotic resistance in bacteria from magpies (Pica pica) and rabbits (Oryctolagus cuniculus) from west Wales. Environ. Microbiol. 2001, 3:658-661.
69. Lofmark S., Jernberg C., Billstrom H., Andersson D.I., Edlund C. Restored fitness leads to long-term persistence of resistant Bacteroides strains in the human intestine. Anaerobe 2008, 14:157-160.
70. López E., Blázquez J. Effect of subinhibitory concentrations of antibiotics on intrachromosomal homologous recombination in Escherichia coli. Antimicrob. Agents Chemother. 2009, 53:3411-3415.
71. Macia M.D., Blanquer D., Togores B., Sauleda J., Perez J.L., Oliver A. Hypermutation is a key factor in development of multiple-antimicrobial resistance in Pseudomonas aeruginosa strains causing chronic lung infections. Antimicrob. Agents Chemother. 2005, 49:3382-3386.
72. Maggiorani Valecillos A., Rodriguez Palenzuela P., Lopez-Solanilla E. The role of several multidrug resistance systems in Erwinia chrysanthemi pathogenesis. Mol. Plant Microbe Interact. 2006, 19:607-613.
73. Maisnier-Patin S., Andersson D.I. Adaptation to the deleterious effects of antimicrobial drug resistance mutations by compensatory evolution. Res. Microbiol. 2004, 155:360-369.
74. Mao E., Lane L., Lee J., Miller J.H. Proliferation of mutators in a cell population. J. Bacteriol. 1997, 179:417-422.
75. Marcusson L.L., Frimodt-Möller N., Hughes D. Interplay in the selection of fluoroquinolone resistance and bacterial fitness. PLoS Pathog. 2009, 5:e1000541.
76. Marshall C.G., Lessard I.A., Park I., Wright G.D. Glycopeptide antibiotic resistance genes in glycopeptide-producing organisms. Antimicrob. Agents Chemother. 1998, 42:2215-2220.
77. Martinez J.L. Antibiotics and antibiotic resistance genes in natural environments. Science 2008, 321:365-367.
78. Martinez J.L. The role of natural environments in the evolution of resistance traits in pathogenic bacteria. Proc. Biol. Sci. 2009, 276:2521-2530.
79. Martinez J.L., Baquero F. Mutation frequencies and antibiotic resistance. Antimicrob. Agents Chemother. 2000, 44:1771-1777.
80. Martinez J.L., Baquero F. Interactions among strategies associated with bacterial infection: pathogenicity, epidemicity, and antibiotic resistance. Clin. Microbiol. Rev. 2002, 15:647-679.
81. Martinez J.L., Baquero F., Andersson D.I. Predicting antibiotic resistance. Nat. Rev. Microbiol. 2007, 5:958-965.
82. Martinez J.L., Fajardo A., Garmendia L., Hernandez A., Linares J.F., Martinez-Solano L., et al. A global view of antibiotic resistance. FEMS Microbiol. Rev. 2009, 33:44-65.
83. Martinez J.L., Sanchez M., Martinez-Solano L., Hernandez A., Garmendia L., Fajardo A., et al. Functional role of bacterial multidrug efflux pumps in microbial natural ecosystems. FEMS Microbiol. Rev. 2009, 33:430-449.
84. Martinez-Martinez L., Pascual A., Jacoby G.A. Quinolone resistance from a transferable plasmid. Lancet 1998, 351:797-799.
85. Massova I., Mobashery S. Kinship and diversification of bacterial penicillin-binding proteins and β-lactamases. Antimicrob. Agents Chemother. 1998, 42:1-17.
86. Maurice F., Broutin I., Podglajen I., Benas P., Collatz E., Dardel F. Enzyme structural plasticity and the emergence of broad-spectrum antibiotic resistance. EMBO Rep. 2008, 9:344-349.
87. Medeiros A.A. Evolution and dissemination of β-lactamases accelerated by generations of β-lactam antibiotics. Clin. Infect. Dis. 1997, 24(Suppl. 1):S19-S45.
88. Miteva V.I., Sheridan P.P., Brenchley J.E. Phylogenetic and physiological diversity of microorganisms isolated from a deep Greenland glacier ice core. Appl. Environ. Microbiol. 2004, 70:202-213.
89. Moritz E.M., Hergenrother P.J. Toxin-antitoxin systems are ubiquitous and plasmid-encoded in vancomycin-resistant enterococci. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:311-316.
90. Morosini M.I., Baquero M.R., Sánchez-Romero J.M., Negri M.C., Galán J.C., del Campo R., et al. Frequency of mutation to rifampicin resistance in Streptococcus pneumoniae clinical strains: hexA and hexB polymorphisms do not account for hypermutation. Antimicrob. Agents Chemother. 2003, 47:1464-1467.
91. Nelson E.C., Elisha B.G. Molecular basis of AmpC hyperproduction in clinical isolates of Escherichia coli. Antimicrob. Agents Chemother. 1999, 43:957-959.
92. Nies D.H. Efflux-mediated heavy metal resistance in prokaryotes. FEMS Microbiol. Rev. 2003, 27:313-339.
93. Nilsson A.I., Zorzet A., Kanth A., Dahlstrom S., Berg O.G., Andersson D.I. Reducing the fitness cost of antibiotic resistance by amplification of initiator tRNA genes. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:6976-6981.
94. Novais Â., Cantón R., Coque T.M., Moya A., Baquero F., Galán J.G. Mutational events in cefotaximase extended-spectrum β-lactamases of the CTX-M-1 cluster involved in ceftazidime resistance. Antimicrob. Agents Chemother. 2008, 52:2377-2382.
95. Novais Â., Comas I., Baquero F., Cantón R., Coque T.M., Moya A., et al. Evolutionary trajectories of β-lactamase CTX-M-1 cluster enzymes: predicting antibiotic resistance. PLoS Pathog. 2010, 6:e1000735.
96. Ohta T. The nearly neutral theory of molecular evolution. Ann. Rev. Ecol. Syst. 1992, 21:263-286.
97. Ohta T., Kimura M. On the constancy of the evolutionary rate of cistrons. J. Mol. Evol. 1971, 1:18-25.
98. Oliver A., Cantón R., Campo P., Baquero F., Blázquez J. High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection. Science 2000, 288:1251-1254.
99. Orencia M.C., Yoon J.S., Ness J.E., Stemmer W.P., Stevens R.C. Predicting the emergence of antibiotic resistance by directed evolution and structural analysis. Nat. Struct. Biol. 2001, 8:238-242.
100. O'Sullivan D.M., McHugh T.D., Gillespie S.H. Analysis of rpoB and pncA mutations in the published literature: an insight into the role of oxidative stress in Mycobacterium tuberculosis evolution?. J. Antimicrob. Chemother. 2005, 55:674-679.
101. Pallecchi L., Bartoloni A., Paradisi F., Rossolini G.M. Antibiotic resistance in the absence of antimicrobial use: mechanisms and implications. Expert. Rev. Anti. Infect. Ther. 2008, 6:725-732.
102. Patterson A.J., Rincon M.T., Flint H.J., Scott K.P. Mosaic tetracycline resistance genes are widespread in human and animal fecal samples. Antimicrob. Agents Chemother. 2007, 51:1115-1118.
103. Paulander W., Maisnier-Patin S., Andersson D.I. Multiple mechanisms to ameliorate the fitness burden of mupirocin resistance in Salmonella typhimurium. Mol. Microbiol. 2007, 64:1038-1048.
104. Pei R., Kim S.C., Carlson K.H., Pruden A. Effect of river landscape on the sediment concentrations of antibiotics and corresponding antibiotic resistance genes (ARG). Water Res. 2006, 40:2427-2435.
105. Pettersson M.E., Sun S., Andersson D.I., Berg O.G. Evolution of new gene functions: simulation and analysis of the amplification model. Genetica 2009, 135:309-324.
106. Piddock L.J. Mechanisms of fluoroquinolone resistance: an update 1994-1998. Drugs 1999, 58:11-18.
107. Pitout J.D., Laupland K.B. Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect. Dis. 2008, 8:159-166.
108. Poelwijk F.J., Kiviet D.J., Weinreich D.M., Tans S.J. Empirical fitness landscapes reveal accessible evolutionary paths. Nature 2007, 445:383-386.
109. Poirel L., Mammeri H., Nordmann P. TEM-121, a novel complex mutant of TEM-type β-lactamase from Enterobacter aerogenes. Antimicrob. Agents Chemother. 2004, 48:4528-4531.
110. Poirel L., Rodriguez-Martinez J.M., Mammeri H., Liard A., Nordmann P. Origin of plasmid-mediated quinolone resistance determinant QnrA. Antimicrob. Agents Chemother. 2005, 49:3523-3525.
111. Prammananan T., Sander P., Springer B., Böttger E.C. RecA-mediated gene conversion and aminoglycoside resistance in strains heterozygous for rRNA. Antimicrob. Agents Chemother. 1999, 43:447-453.
112. Price G. Selection and covariance. Nature 1970, 227:520-521.
113. Ramos J.L., Duque E., Gallegos M.T., Godoy P., Ramos-Gonzalez M.I., Rojas A., et al. Mechanisms of solvent tolerance in Gram-negative bacteria. Ann. Rev. Microbiol. 2002, 56:743-768.
114. Rasila T.S., Pajunen M.I., Savilahti H. Critical evaluation of random mutagenesis by error-prone polymerase chain reaction protocols, Escherichia coli mutator strain, and hydroxylamine treatment. Anal. Biochem. 2009, 388:71-80.
115. Reyrat J.M., Kahn D. Mycobacterium smegmatis: an absurd model for tuberculosis?. Trends Microbiol. 2001, 9:472-473.
116. Robicsek A., Strahilevitz J., Jacoby G.A., Macielag M., Abbanat D., Park C.H., et al. Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase. Nat. Med. 2006, 12:83-88.
117. Robicsek A., Jacoby G.A., Hooper D.C. The worldwide emergence of plasmid-mediated quinolone resistance. Lancet Infect. Dis. 2006, 6:629-640.
118. Ruiz-Garbajosa P., Bonten M.J., Robinson D.A., Top J., Nallapareddy S.R., Torres C., et al. Multilocus sequence typing scheme for Enterococcus faecalis reveals hospital-adapted genetic complexes in a background of high rates of recombination. J. Clin. Microbiol. 2006, 44:2220-2228.
119. Sanchez M.B., Hernandez A., Rodriguez-Martinez J.M., Martinez-Martinez L., Martinez J.L. Predictive analysis of transmissible quinolone resistance indicates Stenotrophomonas maltophilia as a potential source of a novel family of Qnr determinants. BMC Microbiol. 2008, 8:148.
120. Sandegren L., Andersson D.I. Bacterial gene amplification: implications for the evolution of antibiotic resistance. Nat. Rev. Microbiol. 2009, 7:578-588.
121. Seppala H., Klaukka T., Vuopio-Varkila J., Muotiala A., Helenius H., Lager K., et al. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. N. Engl. J. Med. 1997, 337:441-446.
122. Shakya T., Wrigh G.D. Nucleotide selectivity of antibiotic kinase. Antimicrob. Agents Chemother. 2010, 54:1909-1913.
123. Sherman D.R., Mdluli K., Hickey M.J., Arain T.M., Morris S.L., Barry C.E., et al. Compensatory ahpC gene expression in isoniazid-resistant Mycobacterium tuberculosis. Science 1996, 272:1641-1643.
124. Sibold C., Henrichsen J., Konig A., Martin C., Chalkley L., Hakenbeck R. Mosaic pbpX genes of major clones of penicillin-resistant Streptococcus pneumoniae have evolved from pbpX genes of a penicillin-sensitive Streptococcus oralis. Mol. Microbiol. 1994, 12:1013-1023.
125. Simoes R.R., Poirel L., Da Costa P.M., Nordmann P. Seagulls and beaches as reservoirs for multidrug-resistant Escherichia coli. Emerg. Infect. Dis. 2010, 16:110-112.
126. Sirot D., Sirot J., Labia R., Morand A., Courvalin P., Darfeuille-Michaud A., et al. Transferable resistance to third-generation cephalosporins in clinical isolates of Klebsiella pneumoniae: identification of CTX-1, a novel β-lactamase. J. Antimicrob. Chemother. 1987, 20:323-334.
127. Smith C.A., Baker E.N. Aminoglycoside antibiotic resistance by enzymatic deactivation. Curr. Drug Targets Infect. Disord. 2002, 2:143-160.
128. Smith Moland E., Hanson N.D., Herrera V.L., Black J.A., Lockhart T.J., Hossain A., et al. Plasmid-mediated, carbapenem-hydrolysing β-lactamase, KPC-2, in Klebsiella pneumoniae isolates. J. Antimicrob. Chemother. 2003, 51:711-714.
129. Sommer M.O., Dantas G., Church G.M. Functional characterization of the antibiotic resistance reservoir in the human microflora. Science 2009, 325:1128-1131.
130. Souli M., Galani I., Giamarellou H. Emergence of extensively drug-resistant and pandrug-resistant Gram-negative bacilli in Europe. Euro Surveill. 2008, 13:19045.
131. Spratt B.G., Bowler L.D., Zhang Q.Y., Zhou J., Smith J.M. Role of interspecies transfer of chromosomal genes in the evolution of penicillin resistance in pathogenic and commensal Neisseria species. J. Mol. Evol. 1992, 34:115-125.
132. Stanton T.B., Humphrey S.B. Isolation of tetracycline-resistant Megasphaera elsdenii strains with novel mosaic gene combinations of tet(O) and tet(W) from swine. Appl. Environ. Microbiol. 2003, 69:3874-3882.
133. Stepanova M.N., Pimkin M., Nikulin A.A., Koryreva V.K., Agapova E.D., Edelstein M.V. Convergent in vivo and in vitro selection of ceftazidime resistance mutations at position 167 of CTX-M-3 β-lactamase in hypermutable Escherichia coli strains. Antimicrob. Agents Chemother. 2008, 52:1297-1301.
134. Sundqvist M., Geli P., Andersson D.I., Sjölund-Karlsson M., Runehagen A., Cars H., et al. Little evidence for reversibility of trimethoprim resistance after a drastic reduction in trimethoprim use. J. Antimicrob. Chemother. 2010, 65:350-360.
135. Tamae C., Liu A., Kim K., Sitz D., Hong J., Becket E., et al. Determination of antibiotic hypersensitivity among 4,000 single-gene-knockout mutants of Escherichia coli. J. Bacteriol. 2008, 190:5981-5988.
136. Thaker M., Spanogiannopoulos P., Wright G.D. The tetracycline resistome. Cell Mol. Life Sci. 2010, 67:419-431.
137. Thanassi D.G., Cheng L.W., Nikaido H. Active efflux of bile salts by Escherichia coli. J. Bacteriol. 1997, 179:2512-2518.
138. Trindade S., Sousa A., Xavier K.B., Dionisio F., Ferreira M.G., Gordo I. Positive epistasis drives the acquisition of multidrug resistance. PLoS Genet. 2009, 5:e1000578.
139. Turrientes M.C., Baquero M.R., Sánchez M.B., Valdezate S., Escudero E., Berg G., et al. Polymorphic mutation frequencies of clinical and environmental Stenotrophomonas maltophilia populations. Appl. Environ. Microbiol. 2010, 76:1746-1758.
140. Vatopoulos A. High rates of metalloβ-lactamase-producing Klebsiella pneumoniae in Greece-a review of the current evidence. Euro Surveill. 2008, 13:8023.
141. Vila J., Ruiz J., Marco F., Barcelo A., Goni P., Giralt E., et al. Association between double mutation in gyrA gene of ciprofloxacin-resistant clinical isolates of Escherichia coli and MICs. Antimicrob. Agents Chemother. 1994, 38:2477-2479.
142. Wachino J., Yamane K., Suzuki S., Kimura K., Arakawa Y. Prevalence of fosfomycin resistance among CTX-M-producing Escherichia coli clinical isolates in Japan and identification of novel plasmid-mediated fosfomycin-modifying enzymes. Antimicrob. Agents Chemother. 2010, 54:3061-3064.
143. Waksman S.A., Woodruff H.B. The soil as a source of microorganisms antagonistic to disease-producing bacteria. J. Bacteriol. 1940, 40:581-600.
144. Webb V., Davies J. Antibiotic preparations contain DNA: a source of drug resistance genes?. Antimicrob. Agents Chemother. 1993, 37:2379-2384.
145. Weinreich D.M., Delaney N.F., Depristo M.A., Hartl D.L. Darwinian evolution can follow only very few mutational paths to fitter proteins. Science 2006, 312:111-114.
146. Wright G.D. The antibiotic resistome: the nexus of chemical and genetic diversity. Nat. Rev. Microbiol. 2007, 5:175-186.
147. Wright A., Zignol M., Van Deun A., Falzon D., Gerdes S.R., Feldman K., et al. Epidemiology of antituberculosis drug resistance 2002-07: an updated analysis of the Global Project on Anti-Tuberculosis Drug Resistance Surveillance. Lancet 2006, 373:1861-1873.
148. Yoneyama H., Nakae T. Mechanism of efficient elimination of protein D2 in outer membrane of imipenem-resistant Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 1993, 37:2385-2390.
149. Zaccolo M., Gherardi E. The effect of high-frequency random mutagenesis on in vitro protein evolution: a study on TEM-1 β-lactamase. J. Mol. Biol. 1999, 285:775-783.
150. Zhang Y., Heym B., Allen B., Young D., Cole S. The catalase-peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis. Nature 1992, 358:591-593.
151. Zhang W., Fisher J.F., Mobashery S. The bifunctional enzymes of antibiotic resistance. Curr. Opin. Microbiol. 2009, 12:505-511.